FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200014936> ?p ?o ?g. }

• W4200014936 endingPage "e28288" @default.
• W4200014936 startingPage "e28288" @default.
• W4200014936 abstract "Coronavirus disease 2019 (COVID-19) is a viral respiratory disease that spreads rapidly, reaching pandemic status, causing the collapse of numerous health systems, and a strong economic and social impact. The treatment so far has not been well established and there are several clinical trials testing known drugs that have antiviral activity, due to the urgency that the global situation imposes. Drugs with specific mechanisms of action can take years to be discovered, while vaccines may also take a long time to be widely distributed while new virus variants emerge. Thus, drug repositioning has been shown to be a good strategy for defining new therapeutic approaches. Studies of the effect of enriched heparin in the replication of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) in vitro assays justify the advance for clinical tests.A phase I/II triple-blind parallel clinical trial will be conducted. Fifty participants with radiological diagnosis of grade IIA pneumonia will be selected, which will be allocated in 2 arms. Participants allocated in Group 1 (placebo) will receive nebulized 0.9% saline. Participants allocated in Group 2 (intervention) will receive nebulized enriched heparin (2.5 mg/mL 0.9% saline). Both groups will receive the respective solutions on a 4/4 hour basis, for 7 days. The main outcomes of interest will be safety (absence of serious adverse events) and efficacy (measured by the viral load).Protocols will be filled on a daily basis, ranging from day 0 (diagnosis) until day 8." @default.
• W4200014936 created "2021-12-31" @default.
• W4200014936 creator A5000476219 @default.
• W4200014936 creator A5005639812 @default.
• W4200014936 creator A5007167507 @default.
• W4200014936 creator A5016141294 @default.
• W4200014936 creator A5018202329 @default.
• W4200014936 creator A5020871383 @default.
• W4200014936 creator A5023945612 @default.
• W4200014936 creator A5024090944 @default.
• W4200014936 creator A5025585267 @default.
• W4200014936 creator A5026849297 @default.
• W4200014936 creator A5028435018 @default.
• W4200014936 creator A5031225959 @default.
• W4200014936 creator A5031611400 @default.
• W4200014936 creator A5035022859 @default.
• W4200014936 creator A5035609658 @default.
• W4200014936 creator A5046234627 @default.
• W4200014936 creator A5050454549 @default.
• W4200014936 creator A5052918431 @default.
• W4200014936 creator A5060789988 @default.
• W4200014936 creator A5065479327 @default.
• W4200014936 creator A5068110827 @default.
• W4200014936 creator A5080623915 @default.
• W4200014936 creator A5085005396 @default.
• W4200014936 creator A5089936584 @default.
• W4200014936 date "2021-12-23" @default.
• W4200014936 modified "2023-10-18" @default.
• W4200014936 title "Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial." @default.
• W4200014936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34941114" @default.
• W4200014936 hasPublicationYear "2021" @default.
• W4200014936 type Work @default.
• W4200014936 citedByCount "2" @default.
• W4200014936 countsByYear W42000149362023 @default.
• W4200014936 crossrefType "journal-article" @default.
• W4200014936 hasAuthorship W4200014936A5000476219 @default.
• W4200014936 hasAuthorship W4200014936A5005639812 @default.
• W4200014936 hasAuthorship W4200014936A5007167507 @default.
• W4200014936 hasAuthorship W4200014936A5016141294 @default.
• W4200014936 hasAuthorship W4200014936A5018202329 @default.
• W4200014936 hasAuthorship W4200014936A5020871383 @default.
• W4200014936 hasAuthorship W4200014936A5023945612 @default.
• W4200014936 hasAuthorship W4200014936A5024090944 @default.
• W4200014936 hasAuthorship W4200014936A5025585267 @default.
• W4200014936 hasAuthorship W4200014936A5026849297 @default.
• W4200014936 hasAuthorship W4200014936A5028435018 @default.
• W4200014936 hasAuthorship W4200014936A5031225959 @default.
• W4200014936 hasAuthorship W4200014936A5031611400 @default.
• W4200014936 hasAuthorship W4200014936A5035022859 @default.
• W4200014936 hasAuthorship W4200014936A5035609658 @default.
• W4200014936 hasAuthorship W4200014936A5046234627 @default.
• W4200014936 hasAuthorship W4200014936A5050454549 @default.
• W4200014936 hasAuthorship W4200014936A5052918431 @default.
• W4200014936 hasAuthorship W4200014936A5060789988 @default.
• W4200014936 hasAuthorship W4200014936A5065479327 @default.
• W4200014936 hasAuthorship W4200014936A5068110827 @default.
• W4200014936 hasAuthorship W4200014936A5080623915 @default.
• W4200014936 hasAuthorship W4200014936A5085005396 @default.
• W4200014936 hasAuthorship W4200014936A5089936584 @default.
• W4200014936 hasConcept C126322002 @default.
• W4200014936 hasConcept C142724271 @default.
• W4200014936 hasConcept C177713679 @default.
• W4200014936 hasConcept C197934379 @default.
• W4200014936 hasConcept C204787440 @default.
• W4200014936 hasConcept C27081682 @default.
• W4200014936 hasConcept C2777557582 @default.
• W4200014936 hasConcept C2777914695 @default.
• W4200014936 hasConcept C2779134260 @default.
• W4200014936 hasConcept C3008058167 @default.
• W4200014936 hasConcept C524204448 @default.
• W4200014936 hasConcept C535046627 @default.
• W4200014936 hasConcept C71924100 @default.
• W4200014936 hasConcept C89623803 @default.
• W4200014936 hasConceptScore W4200014936C126322002 @default.
• W4200014936 hasConceptScore W4200014936C142724271 @default.
• W4200014936 hasConceptScore W4200014936C177713679 @default.
• W4200014936 hasConceptScore W4200014936C197934379 @default.
• W4200014936 hasConceptScore W4200014936C204787440 @default.
• W4200014936 hasConceptScore W4200014936C27081682 @default.
• W4200014936 hasConceptScore W4200014936C2777557582 @default.
• W4200014936 hasConceptScore W4200014936C2777914695 @default.
• W4200014936 hasConceptScore W4200014936C2779134260 @default.
• W4200014936 hasConceptScore W4200014936C3008058167 @default.
• W4200014936 hasConceptScore W4200014936C524204448 @default.
• W4200014936 hasConceptScore W4200014936C535046627 @default.
• W4200014936 hasConceptScore W4200014936C71924100 @default.
• W4200014936 hasConceptScore W4200014936C89623803 @default.
• W4200014936 hasIssue "51" @default.
• W4200014936 hasOpenAccess W4200014936 @default.
• W4200014936 hasRelatedWork W13785005 @default.
• W4200014936 hasRelatedWork W15178828 @default.
• W4200014936 hasRelatedWork W15367883 @default.
• W4200014936 hasRelatedWork W17453917 @default.
• W4200014936 hasRelatedWork W17603917 @default.
• W4200014936 hasRelatedWork W5251858 @default.
• W4200014936 hasRelatedWork W5401480 @default.
• W4200014936 hasRelatedWork W6454605 @default.
• W4200014936 hasRelatedWork W887925 @default.

• next